In May, we had a very successful Vascular and Endovascular Qualified Training with the attendance of 22 trainees from all around the MEA region.
Endovascular surgery is a minimally invasive procedure that involves using catheters and other tools to access the inside of blood vessels, allowing doctors to treat a variety of conditions, including aneurysms, peripheral arterial disease, and deep vein thrombosis. Endovascular surgery is becoming increasingly popular, as it is less invasive than traditional open surgery, has a shorter recovery time, and often results in fewer complications.
The training was held for 4 days from May 8-11 covering 2 days of Vascular and 2 days of Endo (Advanta V12) with one of Getinge’s global trainers Sunny Bazzi coming from the USA. The diverse range of attendees represented countries such as Saudi Arabia, Syria, Lebanon, Iraq, Oman, Bahrain, Kenya, Mauritius, Algeria, and Egypt.
Trainees expressed their utmost satisfaction with the opportunity to acquaint themselves with the latest products and undergo efficient sales training, which equipped them with essential skills for promoting and selling these advanced medical solutions. Through interactive role plays and firsthand exposure to the products, participants were able to enhance their understanding and confidence in advocating for these cutting-edge technologies.
Beyond its educational merits, the training fostered a conducive environment for networking and cultivating professional relationships among attendees. The connections forged during this event hold the potential to pave the way for future collaborations and advancements in the field of vascular and endovascular surgery.
The resounding success of the Vascular and Endovascular Qualified Training serves as a testament to the growing enthusiasm and commitment of medical practitioners in the MEA region to stay at the forefront of advancements in the field. With access to the latest knowledge and tools, these professionals are well-equipped to provide improved patient care and contribute to the continued progress of vascular and endovascular medicine.